8-KSecurities & Listing

EXELON CORP 8-K Report, Listing Notice (Oct 28, 2005)

Filed October 28, 2005For Securities:EXC

Summary

This Form 8-K filing from Exelon Corporation (EXC), dated October 28, 2005, addresses a minor discrepancy regarding corporate governance disclosures with the New York Stock Exchange (NYSE). Specifically, the NYSE informally notified Exelon that its proxy statement did not explicitly state that the Exelon Lead Director presides over executive sessions of non-management directors, as required by NYSE Listed Company Manual Section 303A.03. Exelon believed its existing disclosures were sufficient, referencing its corporate governance principles which designate the Chair of the Governance Committee as the lead director who presides over these sessions. Despite Exelon's belief that its disclosure was adequate and not material, the NYSE maintained its position. Consequently, Exelon is filing this Form 8-K to supplement its disclosures and formally inform the market about this specific governance practice. While this filing does not indicate any financial distress or significant operational changes, it highlights Exelon's commitment to meeting NYSE listing requirements and maintaining transparent communication with investors regarding its board structure and governance protocols.

Key Highlights

  • 1Exelon Corporation is filing a Form 8-K to address a disclosure requirement from the New York Stock Exchange (NYSE) regarding director responsibilities.
  • 2The NYSE identified that Exelon's proxy statement did not explicitly state the Lead Director presides over executive sessions of non-management directors.
  • 3Exelon's corporate governance principles already designate the Chair of the Corporate Governance Committee as the Lead Director, who presides over these sessions.
  • 4Exelon initially believed its disclosures were sufficient and that the omission was not material.
  • 5The NYSE did not accept Exelon's position, requiring a formal disclosure via Form 8-K.
  • 6This filing serves as a supplemental disclosure to comply with NYSE's interpretation of listing rules, not a reflection of financial or operational issues.

Frequently Asked Questions

This Form 8-K is filed to supplement Exelon's previous disclosures to the New York Stock Exchange (NYSE) regarding its corporate governance practices. Specifically, it clarifies that the Exelon Lead Director presides over executive sessions of non-management directors, a point the NYSE requested to be more explicitly stated than what was included in Exelon's proxy statement.

No, this filing is purely a procedural disclosure related to corporate governance requirements. It does not indicate any financial distress, delisting threats, or failure to meet listing standards. Exelon is making this filing to ensure full compliance with the NYSE's interpretation of its disclosure rules.

According to Exelon's corporate governance principles, the Lead Director is the Chair of the Corporate Governance Committee. This individual presides over and leads the discussion during executive sessions of the non-management directors.

Yes, Exelon initially believed its proxy statement disclosures were sufficient to inform investors that the Lead Director presides at executive sessions. However, the NYSE maintained its position, and Exelon is filing this 8-K to comply with the NYSE's requirement for more specific disclosure.